Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.
The latest feature update for Microsoft Edge is here with a bit of Copilot, security fixes, better cookie settings, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results